SPAC vs IPO: The Real 2026 Comparison for Company Founders
By CT Acquisitions Editorial Team, reviewed by senior M&A advisors. Last reviewed: June 2026.
SPAC vs IPO in 2026 is no longer a speed contest. A SPAC merger still closes in roughly 4 to 6 months versus 6 to 12 months for a traditional IPO, but the SEC’s January 24, 2024 SPAC rules (effective July 1, 2024) stripped away most of the disclosure shortcuts, safe harbors, and marketing freedoms that made SPACs attractive from 2020 through 2021. The choice now turns on three questions: how much sponsor promote dilution will you accept, how much redemption risk can your deal absorb, and how disciplined a post-close shareholder base do you want.
SPAC vs IPO at a glance: the 2026 comparison table
The two paths take a private company public, but the mechanics diverge on almost every operational variable. This side-by-side captures the current state after the 2024 SEC rule changes and the 2022-24 de-SPAC volume collapse.
| Variable | SPAC (de-SPAC merger) | Traditional IPO |
|---|---|---|
| Typical timeline from signing to close | 4 to 6 months | 6 to 12 months from S-1 filing; 12 to 18 months from prep kickoff |
| Direct transaction cost (% of gross proceeds) | 5% to 8% (advisory, legal, PIPE placement) | 7% underwriting spread + $3M to $5M in ancillary costs |
| Sponsor promote dilution | ~20% of post-money equity to SPAC sponsor at $0.002 per share | None |
| Valuation setting mechanism | Negotiated with sponsor + PIPE anchor | Book-built by underwriters against demand |
| Certainty of proceeds at signing | Low; redemption rates averaged 80%+ in 2022-23 cohorts | Moderate; withdrawal risk on weak book, but proceeds locked once priced |
| Forward-looking projections in marketing | Allowed but no longer PSLRA safe harbor after July 2024 | Not permitted in the prospectus; roadshow guidance heavily lawyered |
| SEC review intensity | Full S-4 review + target company financials at PCAOB standard | Full S-1 review |
| Post-close 12-month median share performance (2021-23 cohorts) | Negative 60% or worse per De-SPAC Index tracking | Positive 5% to 15% median for 2023-24 IPO cohort |
| Analyst coverage on day one | Sponsor-driven, limited | Underwriter syndicate coverage typical within 25 days |
| Lockup on insider shares | 6 to 12 months, sponsor-negotiated | 180 days is standard |
Verdict for most founders in 2026: a traditional IPO is the default. A SPAC only wins when the target has a specific story that public-market investors will price harshly (pre-revenue, story-driven, or complex regulatory arc) and the sponsor brings genuine operating value beyond the shell.
What is a SPAC in 2026, after the rule changes
A special purpose acquisition company (SPAC) is a blank-check shell that raises cash in its own IPO, holds the proceeds in a trust account, and then merges with an operating private company within a stated deadline (usually 18 to 24 months). The private target becomes public by absorbing the shell. Under the 2024 SEC rules, the target company is now treated as a co-registrant on the S-4, which extends underwriter-style Section 11 liability to the deal’s financial advisors and PIPE placement agents. The SPAC Research database tracked 46 completed de-SPAC transactions in 2024 versus 199 in 2021, an 77% decline.
The SPAC lifecycle has four discrete stages. Understanding each stage matters because your negotiating position as a target company shifts at every step.
- Sponsor IPO. The sponsor raises $75M to $500M in a units offering (typically one share plus a fraction of a warrant per unit at $10). Cash goes into trust earning short-Treasury yields.
- Target search. The sponsor spends 12 to 18 months hunting for a target. Deadline pressure grows toward month 20.
- Business combination agreement. Sponsor and target negotiate a definitive merger, sponsor promote adjustments, and a PIPE (Private Investment in Public Equity) to backfill anticipated redemptions.
- De-SPAC vote and close. SPAC shareholders vote and can redeem their shares for the $10 trust value plus accrued interest. The deal closes with whatever cash survives redemptions plus PIPE proceeds.
The redemption right is the SPAC’s fundamental structural weakness. In the 2022 cohort tracked by Harvard Law School Forum on Corporate Governance, redemption rates on completed de-SPAC votes exceeded 80% at median. The math punishes targets: a $250M SPAC that redeems 85% delivers only $37.5M of trust cash, forcing the target to either shrink the deal, raise a bigger PIPE at a discount, or walk.
The NYU Stern “SPACs Post-Merger” study by Michael Klausner and colleagues, published in the Yale Law Journal in 2022, documented the average dilution embedded in a SPAC as of the merger vote at roughly 50% of the cash contributed by non-redeeming shareholders. That academic work formed the foundation for many of the disclosure requirements in the 2024 SEC rules, particularly the mandatory dilution table required by Item 1603(b) of the amended rules described in the SEC’s press release announcing the rules.
What is a traditional IPO
A traditional initial public offering (IPO) files a Form S-1 with the SEC, goes through a two-to-four-round comment cycle with the SEC staff, hires bank underwriters to run a book-building roadshow across institutional accounts, and prices the offering the night before the stock begins trading. The underwriters (typically 2 to 6 bookrunners plus co-managers) commit to purchase the shares from the company at the offering price minus a 7% gross spread and resell to their institutional and retail clients.
The IPO produces a specific set of outputs that a SPAC generally cannot match: a book of long-only institutional holders assembled by professional sales teams, syndicate research coverage from banks that meets FINRA quiet-period rules, and a market-tested price. According to Jay Ritter’s IPO database at the University of Florida, first-day IPO returns averaged 18.4% across the 2010-2024 window, and median 3-year buy-and-hold performance from IPO price has consistently outperformed the de-SPAC index.
The full IPO process is codified in the Securities Act of 1933 and its implementing rules. The SEC’s small-business guide to registration requirements lays out the S-1 disclosure regime, and the Financial Industry Regulatory Authority (FINRA) enforces the syndicate quiet-period rules that gate research coverage. Underwriter league tables published by S&P Global Market Intelligence and Dealogic confirm that the bookrunner concentration in US IPOs remains high: Goldman Sachs, Morgan Stanley, J.P. Morgan, Bank of America, and Citigroup together held roughly two-thirds of US IPO bookrunning volume in 2023 and 2024, per Reuters reporting of the underlying data.
SPAC vs IPO timeline: 4-6 months versus 6-12 months
The speed differential remains the SPAC’s cleanest selling point, but the gap has narrowed under the 2024 rules. A typical de-SPAC now runs 4 to 6 months from business combination agreement signing to closing. A traditional IPO runs 6 to 12 months from S-1 filing to the first day of trading, and 12 to 18 months if you count the pre-filing preparation phase (audit uplift, board composition, S-X compliance work, Sarbanes-Oxley readiness).
| Milestone | SPAC (from BCA signing) | Traditional IPO (from S-1 filing) |
|---|---|---|
| Initial regulatory filing | S-4 within 4 weeks | S-1 at day 0 (confidential DRS common) |
| First SEC comment letter | Weeks 6 to 8 | Weeks 4 to 6 |
| Number of SEC comment rounds (median) | 3 to 4 | 2 to 4 |
| Marketing period | PIPE roadshow, 2 to 4 weeks | Institutional roadshow, 8 to 10 business days |
| Shareholder vote | Yes, SPAC shareholders vote and can redeem | No shareholder vote required |
| Total elapsed | 16 to 26 weeks | 26 to 52 weeks |
The 2024 SEC rules added roughly 30 to 60 days to the de-SPAC timeline by requiring the target’s financial statements to be filed with the S-4 (not just at close) and by extending the minimum dissemination window between definitive proxy and vote. Fast SPAC deals that used to close in 90 days are now rare. Practitioner commentary from Wachtell, Lipton, Rosen & Katz and Paul, Weiss confirms that the de-facto de-SPAC timeline for deals signed in late 2024 and 2025 has stretched to a median of about 5.5 months, roughly matching a well-run confidential IPO from DRS submission to pricing.
For traditional IPOs, the timeline is anchored by the SEC’s confidential submission rules for emerging growth companies (EGCs) under the JOBS Act. An EGC as defined by the SEC investor bulletin on the JOBS Act can file a draft registration statement (DRS) confidentially, receive at least one round of SEC comments before going public with the S-1, and then complete the pricing on a compressed public timeline. The PwC IPO readiness guide and the EY Global IPO Trends quarterly report both cite 4 to 6 months from DRS to first trade as a typical elapsed for a well-prepared EGC, with the pre-DRS preparation adding another 6 to 12 months upstream.
Where the SPAC still saves time
The genuine timing advantage lives in market-window flexibility. A SPAC target negotiates its valuation privately, sets its deal terms, and does not need a hot IPO tape to close. In choppy markets (late 2022, mid-2023, spring 2025), the traditional IPO calendar froze while SPAC deals continued to close. A company that must go public against a strategic deadline (financing covenant, contractual liquidity trigger, secondary sale window) sometimes takes the SPAC path just to avoid market-window risk.
SPAC vs IPO cost comparison with a worked example
Direct transaction costs tell only half the cost story. The sponsor promote (20% of post-money equity delivered to the SPAC sponsor for pennies) creates a hidden dilution charge that dwarfs the underwriting spread on almost every deal.
Consider a $500M enterprise value private company targeting $150M in gross proceeds and a $650M post-money equity value. The two paths produce very different owner economics.
| Cost line | SPAC route | Traditional IPO |
|---|---|---|
| Advisory / underwriting fees | $4.5M (3% of proceeds) | $10.5M (7% gross spread) |
| Legal and accounting | $4M to $6M | $3M to $5M |
| Printer, listing, roadshow | $1M | $1M to $1.5M |
| D&O insurance uplift year 1 | $2M to $4M | $1.5M to $3M |
| PIPE placement agent fee | $3M to $4.5M (3% of $100M PIPE) | N/A |
| Direct cash costs subtotal | $14.5M to $20M | $16M to $20M |
| Sponsor promote dilution | ~$130M (20% of $650M equity to sponsor for ~$25,000) | $0 |
| All-in economic cost | ~$144.5M to $150M | $16M to $20M |
The direct cash costs look similar, but the sponsor promote is the killer. On this example, existing owners give up ~20% of the company to the sponsor. In IPO terms, that is like paying a 100%+ underwriting spread. Sponsors have started negotiating promote givebacks (10% to 15% instead of 20%), earnout triggers tied to post-close stock performance, and multi-year vesting, but a 5% to 15% economic transfer to the sponsor remains the baseline.
Sponsor promote: the real dilution math
A standard SPAC sponsor buys founder shares equal to 20% of the post-IPO SPAC shares outstanding for a nominal price ($25,000 for the entire block is typical). At close, those shares convert 1-for-1 into common stock of the merged company. On a $250M SPAC that closes at $10 per share, the sponsor’s economic position is worth roughly $62.5M for a $25,000 investment. That value comes directly out of the target’s pre-deal owners.
Modern deals often carve back part of the promote. Common structures:
- Straight cut: promote reduced from 20% to 10% or 12% at signing.
- Earnout: portion of promote vests only if the stock trades above $12.50, $15, or $17.50 for a defined window in years 1-3.
- Forfeiture-for-cash: sponsor forfeits shares equal to the redemption shortfall to protect the target’s cash-in.
The Harvard Law School Forum’s 2022 SPAC review tracked promote givebacks in 68% of 2022 deals, with an average giveback of 25% of the original promote. That helps but does not erase the structural dilution. Additional practitioner-side data from Weil, Gotshal & Manges and Sullivan & Cromwell practice updates showed that by 2023 and 2024, more than three-quarters of live de-SPAC negotiations involved a promote restructuring at signing.
Warrants attached to the sponsor’s founder units add another compensation layer. Sponsor warrants typically strike at $11.50 and become exercisable after close, providing upside if the merged company trades above the strike price. WilmerHale practice notes point out that these warrants can add another 2% to 4% of dilution beyond the base 20% promote when they vest and are exercised, so the true peak dilution can approach 25% of post-money equity in the worst structured deals.
The SEC’s 2024 SPAC rules and what they changed
The SEC adopted final rules on January 24, 2024 (effective July 1, 2024) that fundamentally repriced SPACs against IPOs. The rules eliminate the Private Securities Litigation Reform Act (PSLRA) safe harbor for forward-looking statements in SPAC transactions, require target company financials to meet full PCAOB audit standards on the S-4, and impose underwriter-style liability on financial advisors and PIPE placement agents who help sell the de-SPAC.
The practical effect: SPACs lost the three things that made them structurally different from IPOs.
| Feature | Pre-2024 SPAC | Post-2024 SPAC | Traditional IPO |
|---|---|---|---|
| Projections in marketing | Freely used, PSLRA safe harbor | Allowed but no safe harbor; heightened liability | Not permitted |
| Target financial statements | Reviewed audits often acceptable | PCAOB audits required at S-4 | PCAOB audits required at S-1 |
| Financial advisor liability | Advisory only, no Section 11 | Section 11 style liability where acting as underwriter | Full Section 11 underwriter liability |
| Time between definitive proxy and vote | ~20 days | Minimum 20 days, longer in practice | N/A |
| Enhanced disclosure of sponsor conflicts and dilution | Basic | Item 1603 (b) mandatory tabular dilution disclosure | N/A |
Post-rule, a de-SPAC target now bears the same disclosure discipline, projection restraint, and audit rigor as an IPO issuer, but still absorbs sponsor promote dilution and redemption risk. That is why many advisors call the 2024 rules the “de-SPAC extinction event.” Legal-industry commentary from Davis Polk & Wardwell, Gibson Dunn, and Kirkland & Ellis published across 2024 and 2025 argued that most of the SPAC market’s economic rationale disappeared once the safe harbors and audit shortcuts were closed.
The Holding Foreign Companies Accountable Act and the follow-on PCAOB China audit inspection agreements also shifted the SPAC landscape by making US listings for China-based issuers materially harder to complete. A subset of the pre-2022 SPAC market had been driven by Chinese-founded targets looking for a US public listing. That flow has largely disappeared and the remaining SPAC deals concentrate in US and European domiciles.
Redemption risk: the SPAC’s Achilles heel
SPAC shareholders have a contractual right to redeem their shares for the $10 trust value at the de-SPAC vote, regardless of how they vote. Redemption rates measure the percentage of trust cash that walks out the door before close. High redemption rates gutted the 2022-24 SPAC cohort.
| Vintage | Average redemption rate | Completed de-SPAC count | Median cash to target at close |
|---|---|---|---|
| 2020 | ~24% | Approximately 65 | ~$150M |
| 2021 | ~52% | 199 | ~$120M |
| 2022 | ~80% | 103 | ~$40M |
| 2023 | ~87% | 96 | ~$25M |
| 2024 | ~85% | 46 | ~$30M |
Data compiled from SPAC Research, SPAC Insider, and Deal Point Data disclosures. In practical terms, a de-SPAC signed in 2024 typically closes with less than 15% of trust cash intact, forcing the target to either raise a PIPE that fills the gap or accept a much smaller capital raise than announced. Independent aggregation by Bloomberg and The Wall Street Journal corroborated the redemption trajectory in 2023 and 2024, with several front-page pieces documenting individual deals that closed with under 5% of trust cash after redemption.
PIPE dependency after 2022
Private Investment in Public Equity (PIPE) deals became the de facto financing tool for de-SPAC transactions once redemptions spiked. A PIPE is a committed equity investment from institutional investors (hedge funds, family offices, strategic corporates) that closes concurrently with the de-SPAC, replacing redeemed trust cash. In 2021 the median PIPE priced at $10 per share (no discount). By 2023, PIPE anchors demanded structural protections: $8 to $9 per share pricing, downside adjustments if the stock traded below a threshold post-close, warrant coverage, and registration rights within 30 days of close. The Deloitte SPAC study series flagged PIPE availability as the single biggest execution risk in de-SPAC deals from 2022 forward.
Disclosure differences: projections, S-1 versus S-4
Traditional IPOs cannot include forward-looking financial projections in the prospectus. Underwriters guide the market through the roadshow using historical financials, KPI trends, and management discussion, but the actual S-1 stops at reported numbers plus MD&A commentary. SPAC targets historically relied on 5-year projections in the S-4 to justify valuations, especially for pre-revenue or story-heavy issuers (electric vehicles, space, biotech, quantum, blockchain).
The 2024 rules did not ban projections in S-4s outright, but by killing the PSLRA safe harbor, they made projections a litigation risk. Targets and sponsors now either omit projections, disclose them with heavy hedging language, or ring-fence them behind explicit reliance disclaimers. On practice, more than 60% of S-4s filed between July 2024 and mid-2025 either dropped forward-looking financial projections entirely or shortened them to 12 months, per practitioner reports collected by Skadden and Freshfields.
The projection reset had a compounding effect on retail investor participation. During 2020 and 2021, retail investors were drawn to SPAC targets partly by the hockey-stick revenue projections that IPO issuers could not legally include in an S-1. Once projections became a litigation minefield, that informational asymmetry evaporated, and retail flows to SPAC deals collapsed in parallel with the professional PIPE market drying up. Financial Times and Barron’s both traced this shift across their 2023 and 2024 SPAC coverage.
Post-deal trading: the honest data
Post-close performance is where the SPAC vs IPO story ends most one-sidedly. The De-SPAC Index (compiled by IndxxDaily and referenced by multiple research providers) fell approximately 78% from its March 2021 peak to Q4 2023. Traditional IPOs from the same period, tracked by the Renaissance IPO ETF (IPO), fell roughly 45% peak-to-trough over the same window and recovered faster.
Named deal outcomes from the 2022-25 vintages illustrate the volatility gap.
| Company | Route | Year public | First-day return | Approximate return through mid-2026 |
|---|---|---|---|---|
| Reddit (RDDT) | Traditional IPO | 2024 | +48% first day | Positive, materially above IPO price |
| Arm Holdings (ARM) | Traditional IPO | 2023 | +24.7% first day | Positive, above IPO price |
| Instacart (CART) | Traditional IPO | 2023 | +12% first day | Mixed, roughly flat to modestly below |
| Klaviyo (KVYO) | Traditional IPO | 2023 | +9% first day | Positive, modest gain |
| Trump Media (DJT) | De-SPAC | 2024 | Extreme volatility on first day | Down materially from post-merger peak |
| Rumble (RUM) | De-SPAC | 2022 | Roughly flat | Down materially versus $10 base |
| WeWork (WE) | De-SPAC | 2021 | +13% first day | Delisted, Chapter 11 filed November 2023 |
| Lucid Motors (LCID) | De-SPAC | 2021 | Strong initial run | Down materially from post-merger peak |
| Nikola (NKLA) | De-SPAC | 2020 | Strong initial run | Filed Chapter 11 February 2025 |
| BuzzFeed (BZFD) | De-SPAC | 2021 | Weak | Down materially versus $10 base |
The pattern is consistent: 2023-24 traditional IPOs that survived the volume drought delivered acceptable-to-strong performance because bankers were pickier about which companies could clear the market. De-SPAC issuers cleared a lower bar, so post-close disappointment rates ran higher.
Systematic academic work supports the anecdote. National Bureau of Economic Research (NBER) working paper 30758 by Bai, Ma, and Zheng (2023) studied 285 de-SPAC mergers and reported average 12-month post-merger returns of negative 60% versus a benchmark IPO cohort return of positive 8%. The JSTOR archived version of the Klausner-Ohlrogge paper “A Sober Look at SPACs” (originally posted on SSRN) reached similar conclusions using earlier data. Morningstar equity research and S&P Dow Jones Indices equity performance databases both provide readily audited public benchmarks for anyone who wants to verify the returns gap.
The IPO discount and money left on the table
The IPO process has its own pathology. Underwriters price to reward their institutional clients with a first-day pop, which means IPO issuers systematically leave money on the table. The 18.4% average first-day return in the Ritter dataset represents billions of dollars of unrealized value transferred from issuers to first-day allocators. For a $150M IPO priced at $15 that pops to $18, the issuer effectively raised $150M at a market-clearing price of $180M and paid a spread that was closer to 25% economically once you count the underpricing.
Direct listings emerged partly to solve this problem. The New York Stock Exchange and Nasdaq both accept direct listings under revised rules, and the Federal Register archive documents the December 2020 SEC rule change that allowed primary capital raises inside a direct listing. Even so, direct listing volume remains a rounding error compared to traditional IPO issuance because most companies still want the marketing scaffolding and hand-holding that a bookrunner syndicate provides.
When a SPAC still wins in 2026
A SPAC remains the better path in specific, narrow situations. Founders should not choose a SPAC by default, but should recognize the fact patterns where sponsor promote dilution is a fair price.
- Pre-revenue or story-heavy issuer. Companies with real technology but limited revenue history (deep-tech, defense-tech, small-modular-nuclear, autonomous systems) may fail to clear an IPO book. A SPAC lets the story travel to public markets without a book-build stress test.
- Foreign issuer with SEC-registered acquiror. Non-US targets pursuing a US listing sometimes prefer the merger structure because a sponsor with US market access shortens the underwriter-selection phase.
- Sponsor with operating value beyond the shell. A minority of sponsors bring board-level operators, customer introductions, or capital markets access that the target could not otherwise access. In those cases, the promote is a payment for genuine strategic value, not a rent.
- Contractual liquidity deadline. Existing preferred shareholders, PE sponsors near fund-life expiry, or synthetic secondary structures sometimes need certainty of close on a defined date. A SPAC provides that certainty (subject to the redemption caveat).
When a traditional IPO wins
For most $200M-plus revenue companies with cleanable audits, positive unit economics, and a category with public comparables, a traditional IPO is the default choice in 2026. The reasons are structural.
- You pay ~7% one time, not 20%+ economic dilution. The IPO underwriting spread is real cash, but it is a fraction of the sponsor promote in equity terms.
- The book you receive is disciplined. Long-only institutional buyers who cleared a roadshow tend to hold longer, trade less, and support secondary offerings and follow-on capital raises.
- Analyst coverage arrives on schedule. Syndicate research comes within the 25-day quiet period expiration and provides published price targets that anchor buy-side attention.
- Valuation is market-tested. A book-built IPO price rarely diverges from post-listing trading by more than 15% in either direction. Sponsor-set SPAC valuations often reset by 40%-plus at redemption.
Standard IPO preparation runway
A pre-IPO company should begin its preparation 18 to 24 months ahead of the target file date. The workstream includes financial audit uplift to PCAOB standard, Sarbanes-Oxley 404(a) readiness, board composition (independent audit, comp, and nom-gov committees), equity compensation plan restructuring, and legal-entity cleanup. Founders who compress this runway to under 12 months typically discover material weaknesses in internal controls during the SEC comment phase and either delay or accept restated financials.
The SEC’s EDGAR filing system is where the S-1 and all subsequent public disclosures live. Company counsel typically coordinates with the transfer agent (often Computershare or Broadridge) and the depositary (DTCC) to ensure book-entry share settlement is ready for the first trade day. The American Institute of CPAs (AICPA) maintains audit and attest standards that intersect with PCAOB requirements for public-company auditors. Coordinating the audit uplift with the S-1 timeline is the single most common source of last-minute delays for first-time issuers, per Grant Thornton IPO practice guidance.
Alternatives to both: direct listing, Reg A+, and Rule 144A
Not every founder wants a SPAC or a traditional IPO. Three alternative paths exist.
| Path | How it works | Typical size | Best for |
|---|---|---|---|
| Direct listing | Existing shares listed; no new capital raised (or new capital via primary DL after 2021 SEC rule change) | $500M-plus market cap | Category leaders with brand strength who do not need cash (Spotify 2018, Slack 2019, Coinbase 2021) |
| Reg A+ Tier 2 | SEC-qualified offering to retail without full IPO process | Up to $75M in a 12-month window | Consumer brands with retail-affinity audiences; more marketing tool than capital solution |
| Rule 144A / Regulation S | Private placement to qualified institutional buyers; no US public registration | $100M-plus | Foreign issuers or debt-focused financings; not a true going-public path but sometimes a bridge |
Direct listings deserve special attention because they eliminate underwriting spread while retaining traditional-IPO disclosure discipline. Since the SEC’s December 2020 rule change allowing primary capital raises in direct listings, this path has become more viable for scaled companies. Palantir and Coinbase both used direct listings successfully, though both had strong brand pull that a middle-market issuer typically lacks.
Reg A+ Tier 2 remains a niche path. The SEC Reg A+ overview page describes the offering circular process and the $75M annual cap. Consumer-facing issuers occasionally use Reg A+ as a hybrid capital raise plus brand marketing exercise, but the path does not deliver the institutional book of holders that a traditional IPO produces. Rule 144A private placements to qualified institutional buyers (QIBs) serve a different purpose: they let issuers tap the institutional bid without registering, but they do not create a US-listed public security, so they are usually a step on the road to a full IPO rather than a substitute.
Public REITs, SPCs, and single-purpose acquisition vehicles
A separate branch of the going-public conversation involves special-purpose vehicles that are not SPACs in the classic sense. Public real estate investment trusts (REITs) file S-11 registrations under a bespoke SEC regime, and business development companies (BDCs) register under the Investment Company Act of 1940. Both paths deliver access to public markets but with tax and disclosure regimes that differ materially from a C-corp IPO. Founders whose businesses have significant real estate or lending assets should consult the Nareit resources and the SIFMA BDC guides before deciding between a C-corp IPO and a REIT or BDC path.
Founder decision framework: how to actually choose
The SPAC vs IPO question resolves along five dimensions. Score your company honestly on each; the sum points to the right path.
- Revenue scale. Under $100M ARR pushes toward SPAC or delay; over $200M ARR opens the traditional IPO path cleanly.
- Category comparability. If public peers trade with defensible multiples, IPO wins. Novel categories with no comparables sometimes need SPAC storytelling.
- Cash need urgency. Need $100M-plus in 6 months? SPAC (if you accept redemption risk) or private crossover round. Need $250M-plus with certainty in 12 months? IPO.
- Founder retention priority. Sponsor promote dilutes existing owners. If founder economics are the top priority, IPO wins on math.
- Volatility tolerance post-close. Founders who cannot tolerate a 60%+ drawdown in the first 90 days should choose IPO. SPAC post-close volatility is structural.
A useful rule of thumb: if you are choosing SPAC purely for speed, choose IPO instead. The 2024 rules narrowed the timing gap enough that “6 months faster” is no longer worth 20% of your company.
SPAC vs IPO market data: 2021 peak to 2026 rebalance
The paper case for a SPAC is easier to make when the market data is visible. Between 2020 and mid-2021, SPACs raised roughly $250 billion across 861 IPOs, per SPAC Research aggregation. That period included the largest single quarter of SPAC IPO issuance ever recorded (Q1 2021, roughly 300 SPAC IPOs). The volume rolled over sharply once the SEC began signaling concern in April 2021, and the collapse accelerated through the 2022 and 2023 vintages.
| Year | SPAC IPO count | SPAC IPO proceeds | De-SPAC mergers completed | US traditional IPO proceeds |
|---|---|---|---|---|
| 2020 | Approximately 248 | ~$83B | ~65 | ~$78B |
| 2021 | 613 | ~$162B | 199 | ~$155B |
| 2022 | 86 | ~$13B | 103 | ~$9B |
| 2023 | 31 | ~$3.9B | 96 | ~$19B |
| 2024 | ~57 | ~$9.5B | 46 | ~$30B |
The takeaways: US traditional IPO proceeds fell 94% from 2021 to 2022, and SPAC IPO issuance fell 92% over the same window. Both markets bottomed together in 2022, then IPOs rebuilt faster while SPACs continued to shed volume through 2024. Renaissance Capital IPO tracking and RSM US capital markets research both aggregate this data quarterly and publish year-end reviews that any founder can reference before making a path decision.
The trajectory since Q4 2024 has been a modest IPO rebound and a continued SPAC decline. Multiple large tech names filed confidential DRS registrations in 2025 that were still in the review pipeline as of Q2 2026, per Reuters and Reuters finance filing trackers. SPAC IPO count for 2025 dropped again on a percentage basis versus 2024, per the ongoing SPAC Research monthly digest.
How CT Acquisitions thinks about going-public paths for lower-middle-market founders
Most owners of $5M to $50M EBITDA businesses do not have a clean fit for either a SPAC or a traditional IPO. Public-market minimum float requirements (typically $75M-plus for NYSE / Nasdaq listings) and Sarbanes-Oxley compliance costs ($1.5M-plus per year in incremental audit, insurance, and reporting expense) make going public uneconomic below roughly $150M in equity value. For most CT Acquisitions clients, the better exit path is a private M&A sale to a strategic acquirer, a private equity platform, or a family office, at multiples that often clear or exceed comparable public trading multiples with none of the disclosure burden.
When a client is genuinely a candidate to go public, we help them stress-test the choice honestly. We are not a SPAC sponsor and we do not underwrite IPOs, so our incentive is aligned with the founder rather than with a deal fee tied to a specific path. Practical guardrails we apply:
- Model both paths on the specific facts of the business, including sponsor promote proposals if a SPAC is on the table.
- Compare the going-public case to a private M&A exit at current market comparables using our how to value a business framework.
- Introduce founders to bank underwriters, direct-listing specialists, and SPAC sponsors from our network without accepting referral fees from any of them.
- Advise on earnout structures, tender offer mechanics, and secondary sale windows that let founders take partial liquidity without a public listing.
For most owners we work with, the disciplined path is our sell-side advisory engagement, or a preparatory workstream aligned with our 2026 guide to selling a business. Founders who want a clean-eyed comparison of the SPAC vs IPO decision alongside a private M&A alternative can schedule a 30-minute exit-readiness call at ctacquisitions.com/contact-us/.
Frequently asked questions
Is a SPAC better than an IPO?
A SPAC is not better than an IPO for most companies in 2026. SPACs still close 4 to 6 months versus 6 to 12 months for a traditional IPO, but the SEC’s 2024 rules eliminated most SPAC disclosure advantages, and sponsor promote dilution costs targets roughly 15% to 20% of post-money equity. Traditional IPOs remain the default choice for revenue-generating companies with public-market comparables.
What is the disadvantage of a SPAC?
The primary SPAC disadvantages are sponsor promote dilution (about 20% of post-money equity handed to the sponsor at pennies), redemption risk (2022-24 median redemption rates exceeded 80%, gutting cash proceeds), PIPE dependency (post-close capital must be lined up before signing), and structurally worse post-close trading performance. The De-SPAC Index fell roughly 78% from March 2021 through late 2023.
Why would a company do a SPAC instead of an IPO?
Companies choose a SPAC over an IPO in three main scenarios: they are pre-revenue or story-heavy and would fail an IPO roadshow; they need certainty of close on a specific date because of contractual triggers; or the SPAC sponsor brings operating value (customers, board expertise, capital markets access) beyond the shell that the company could not otherwise access. Speed alone is no longer a good reason after the 2024 SEC rules.
How does a SPAC sponsor make money?
SPAC sponsors earn through the sponsor promote, which typically grants the sponsor 20% of post-merger equity for roughly $25,000 (about $0.002 per share). At a $650M post-money equity value, a sponsor’s promote is worth about $130M. Modern deals often reduce the promote through partial forfeitures, earnout triggers tied to post-close stock performance, or multi-year vesting.
Is a SPAC riskier than an IPO for the target company?
Yes, on almost every measurable dimension. The SPAC target absorbs redemption risk (median 80%-plus in 2022-24 vintages, gutting cash proceeds), sponsor promote dilution (typically 15% to 20% of the company), and materially worse post-close trading performance. Traditional IPOs deliver a book of long-only institutional holders and analyst coverage that supports the stock through the first 12 months. SPAC targets do not.
How much does an IPO cost in 2026?
A traditional IPO costs approximately 7% of gross proceeds in underwriting spread plus $3M to $5M in legal, accounting, printer, and D&O insurance costs. A $150M IPO therefore costs about $13.5M to $15.5M all in. Add 12 to 18 months of pre-IPO preparation costs (audit uplift, Sarbanes-Oxley readiness, board composition) at roughly $1.5M to $3M for a first-time issuer.
What is the sponsor promote in a SPAC?
The sponsor promote is founder stock issued to the SPAC sponsor at IPO for a nominal price, typically equal to 20% of the post-IPO SPAC shares outstanding. At close, the promote converts to common stock of the merged company. On a $250M SPAC closing at $10 per share, the promote is worth about $62.5M for a $25,000 investment. Modern deals often negotiate promote givebacks of 25% or more.
What replaced SPACs after the 2024 SEC rules?
Traditional IPOs regained market share, with 2024 US IPO proceeds returning to roughly $30 billion versus a $155 billion peak in 2021 and a $9 billion trough in 2022. Direct listings, private placements under Rule 144A, crossover private rounds from public-market investors, and continued private M&A exits absorbed the flow that would have gone to SPACs. Private M&A to strategic and financial buyers remains the largest single exit path for lower-middle-market companies.